GB0225384D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0225384D0
GB0225384D0 GBGB0225384.7A GB0225384A GB0225384D0 GB 0225384 D0 GB0225384 D0 GB 0225384D0 GB 0225384 A GB0225384 A GB 0225384A GB 0225384 D0 GB0225384 D0 GB 0225384D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0225384.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0225384.7A priority Critical patent/GB0225384D0/en
Publication of GB0225384D0 publication Critical patent/GB0225384D0/en
Priority to AU2003293635A priority patent/AU2003293635A1/en
Priority to PCT/EP2003/012068 priority patent/WO2004039822A2/en
Priority to ARP030103954A priority patent/AR041860A1/es
Priority to EP03788981A priority patent/EP1558625A2/en
Priority to US10/533,461 priority patent/US7351696B2/en
Priority to JP2004547617A priority patent/JP2006506389A/ja
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
GBGB0225384.7A 2002-10-31 2002-10-31 Novel compounds Ceased GB0225384D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB0225384.7A GB0225384D0 (en) 2002-10-31 2002-10-31 Novel compounds
AU2003293635A AU2003293635A1 (en) 2002-10-31 2003-10-29 4'' - modified erythromycin derivatives
PCT/EP2003/012068 WO2004039822A2 (en) 2002-10-31 2003-10-29 4’’ - modified erythromycin derivatives
ARP030103954A AR041860A1 (es) 2002-10-31 2003-10-29 Compuesto macrolido de oxima sustituido en la posicion 4'', procedimiento de preparacion del mismo, su uso para preparar un medicamento y composicion farmaceutica que lo comprende
EP03788981A EP1558625A2 (en) 2002-10-31 2003-10-29 4''-modified erythromycin derivatives
US10/533,461 US7351696B2 (en) 2002-10-31 2003-10-29 Compounds
JP2004547617A JP2006506389A (ja) 2002-10-31 2003-10-29 ４”修飾エリスロマイシン誘導体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0225384.7A GB0225384D0 (en) 2002-10-31 2002-10-31 Novel compounds

Publications (1)

Publication Number Publication Date
GB0225384D0 true GB0225384D0 (en) 2002-12-11

Family

ID=9946942

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0225384.7A Ceased GB0225384D0 (en) 2002-10-31 2002-10-31 Novel compounds

Country Status (7)

Country Link
US (1) US7351696B2 (https=)
EP (1) EP1558625A2 (https=)
JP (1) JP2006506389A (https=)
AR (1) AR041860A1 (https=)
AU (1) AU2003293635A1 (https=)
GB (1) GB0225384D0 (https=)
WO (1) WO2004039822A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0310980D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
ES2278319T3 (es) * 2003-05-13 2007-08-01 Glaxo Group Limited Nuevos compuestos con 14 y 15 miembros en el anillo.
GB0310984D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310979D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
WO2005108412A1 (en) * 2004-05-06 2005-11-17 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Ester linked macrolides useful for the treatment of microbial infections
GB0424959D0 (en) 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424951D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424961D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424958D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
WO2006120541A1 (en) 2005-05-10 2006-11-16 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Ether linked macrolides useful for the treatment of microbial infections
WO2012038372A1 (en) 2010-09-20 2012-03-29 Novartis Ag Novel process for the preparation of 9-deoxo-9a-aza- 9a-homoerythromycin a modified in the c-4'' of the cladinose ring by an epoxide group

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1204288A (en) 1987-02-24 1988-08-25 Beecham Group Plc Erythromycins
WO1996034007A1 (es) * 1995-04-27 1996-10-31 Laboratorios Aranda, S.A. De C.V. Derivados de quinolonilcarboxieritromicina y composiciones farmaceuticas que los contienen
AU710532B2 (en) * 1996-05-07 1999-09-23 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
HUP0201516A3 (en) 1999-05-24 2003-03-28 Pfizer Prod Inc 13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them
US6946446B2 (en) 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
ATE312839T1 (de) 2000-02-24 2005-12-15 Abbott Lab Anti-infektionsmittel, die gegen gegenüber mehreren arzneimitteln resistente bakterienstämme nützlich sind
GB0127349D0 (en) * 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides

Also Published As

Publication number Publication date
AU2003293635A1 (en) 2004-05-25
AU2003293635A8 (en) 2004-05-25
US7351696B2 (en) 2008-04-01
JP2006506389A (ja) 2006-02-23
WO2004039822A2 (en) 2004-05-13
US20070037757A1 (en) 2007-02-15
WO2004039822A3 (en) 2004-07-08
AR041860A1 (es) 2005-06-01
EP1558625A2 (en) 2005-08-03

Similar Documents

Publication Publication Date Title
GB0202216D0 (en) Novel compounds
GB0205256D0 (en) Novel compounds
GB0202679D0 (en) Novel compounds
GB0207249D0 (en) Novel compounds
GB0225384D0 (en) Novel compounds
GB0207246D0 (en) Novel compounds
GB0203299D0 (en) Novel compounds
GB0200025D0 (en) Novel compounds
GB0204252D0 (en) Novel compounds
GB0206196D0 (en) Novel compounds
GB0202219D0 (en) Novel compounds
GB0203902D0 (en) Novel compounds
GB0203901D0 (en) Novel compounds
GB0203680D0 (en) Novel compounds
GB0203677D0 (en) Novel compounds
GB0203673D0 (en) Novel compounds
GB0203437D0 (en) Novel compounds
GB0203369D0 (en) Novel compounds
GB0203363D0 (en) Novel compounds
GB0203301D0 (en) Novel compounds
GB0203300D0 (en) Novel compounds
GB0204255D0 (en) Novel compounds
GB0204305D0 (en) Novel compounds
GB0202637D0 (en) Novel compounds
GB0204758D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)